Total Payments
$8,792
2024 Payments
$907.17
Companies
49
Transactions
372
Medicare Patients
14,649
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$7,943 (90.3%)
Travel$842.82 (9.6%)
Education$6.25 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,943 | 367 | 90.3% |
| Travel and Lodging | $842.82 | 4 | 9.6% |
| Education | $6.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,976 | 42 | $0 (2024) |
| ABIOMED | $768.18 | 11 | $0 (2024) |
| Abbott Laboratories | $610.49 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $589.96 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $570.44 | 36 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $487.28 | 31 | $0 (2024) |
| PFIZER INC. | $445.58 | 26 | $0 (2024) |
| Medtronic Vascular, Inc. | $405.16 | 6 | $0 (2020) |
| Amgen Inc. | $299.00 | 20 | $0 (2024) |
| Teleflex LLC | $285.17 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $907.17 | 46 | Teleflex LLC ($152.23) |
| 2023 | $870.34 | 46 | Abbott Laboratories ($167.33) |
| 2022 | $908.84 | 41 | ABIOMED ($169.38) |
| 2021 | $626.68 | 36 | Janssen Pharmaceuticals, Inc ($148.89) |
| 2020 | $771.50 | 17 | Cardiovascular Systems Inc. ($226.46) |
| 2019 | $1,610 | 65 | Boston Scientific Corporation ($652.46) |
| 2018 | $2,054 | 78 | BOSTON SCIENTIFIC CORPORATION ($747.60) |
| 2017 | $1,043 | 43 | BOSTON SCIENTIFIC CORPORATION ($376.88) |
All Payment Transactions
372 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.44 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.55 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Vascular | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Obesity | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Teleflex LLC | TRAPLINER (Device) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.33 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: Cardiovascular | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $18.18 | General |
| Category: Coronary | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $33.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Cardiovascular | ||||||
| 07/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiology | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 4,548 | 8,265 | $1.8M | $563,504 |
| 2022 | 44 | 3,492 | 5,173 | $1.4M | $443,861 |
| 2021 | 41 | 3,219 | 4,572 | $1.3M | $439,234 |
| 2020 | 36 | 3,390 | 4,852 | $1.4M | $454,226 |
Total Patients
14,649
Total Services
22,862
Medicare Billing
$1.9M
Procedure Codes
175
All Medicare Procedures & Services
175 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 273 | 1,638 | $139,230 | $78,384 | 56.3% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 14 | 14 | $197,400 | $45,581 | 23.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 204 | 1,159 | $150,670 | $45,031 | 29.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 105 | 105 | $115,500 | $35,888 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 299 | 356 | $74,760 | $31,351 | 41.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 186 | 192 | $162,530 | $28,291 | 17.4% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 24 | 24 | $64,880 | $25,490 | 39.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 178 | 181 | $93,215 | $25,058 | 26.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 104 | 207 | $39,330 | $18,169 | 46.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 165 | 458 | $50,380 | $17,665 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 146 | 146 | $39,420 | $16,791 | 42.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 113 | 114 | $41,040 | $15,455 | 37.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 87 | 348 | $33,060 | $15,394 | 46.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 126 | 239 | $29,875 | $14,590 | 48.8% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 30 | 60 | $35,100 | $13,770 | 39.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 29 | 36 | $43,920 | $13,511 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 202 | 208 | $31,200 | $13,121 | 42.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 61 | 61 | $79,300 | $10,817 | 13.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 112 | $19,936 | $10,595 | 53.1% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 180 | 180 | $30,150 | $10,460 | 34.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 66 | 66 | $32,340 | $9,524 | 29.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 46 | 46 | $21,390 | $8,796 | 41.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 101 | 205 | $16,400 | $7,633 | 46.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 590 | 711 | $46,215 | $7,175 | 15.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 138 | 138 | $40,020 | $6,940 | 17.3% |
About Dr. George Mueller, DO
Dr. George Mueller, DO is a Cardiovascular Disease healthcare provider based in Mechanicsville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2009. The National Provider Identifier (NPI) number assigned to this provider is 1154557601.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Mueller, DO has received a total of $8,792 in payments from pharmaceutical and medical device companies, with $907.17 received in 2024. These payments were reported across 372 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($7,943).
As a Medicare-enrolled provider, Mueller has provided services to 14,649 Medicare beneficiaries, totaling 22,862 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 175 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Mechanicsville, VA
- Active Since 06/10/2009
- Last Updated 10/30/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1154557601
Products in Payments
- Impella (Device) $768.18
- ELIQUIS (Drug) $597.81
- XARELTO (Drug) $570.44
- LifeVest (Device) $487.28
- GENERAL VASCULAR ACCESS (Device) $454.11
- ENTRESTO (Drug) $435.63
- Resolute (Device) $320.02
- GENERAL VASCULAR ACCESS (Device) $285.32
- WOLVERINE (Device) $285.11
- Corlanor (Drug) $232.28
- CROSSBOSS (Device) $201.42
- JETSTREAM (Device) $191.03
- Coronary Orbital Atherectomy System (Device) $187.14
- TURNPIKE (Device) $160.24
- LEQVIO (Drug) $154.33
- SYNERGY BIOABSORBABLE POLYMER DRUG-ELUTING STENT SYSTEM (Device) $149.92
- Absorb GT1 (Device) $119.55
- MULTAQ (Drug) $119.31
- JOT DX (Device) $113.58
- BRILINTA (Drug) $102.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Mechanicsville
Harpreet Grewal, M.d, M.D
Cardiovascular Disease — Payments: $99,342
Cardiovascular Disease $99,342
Dr. Sameer Rohatgi, M.d, M.D
Cardiovascular Disease — Payments: $9,349
Cardiovascular Disease $9,349
Pindipapanahalli Ravindra, Md, MD
Cardiovascular Disease — Payments: $4,347
Cardiovascular Disease $4,347
Stanley Tucker, Md, MD
Cardiovascular Disease — Payments: $2,879
Cardiovascular Disease $2,879
Dr. Timothy Hagemann, M.d, M.D
Cardiovascular Disease — Payments: $2,614
Cardiovascular Disease $2,614
Dr. Dean Caven, M.d, M.D
Cardiovascular Disease — Payments: $2,577
Cardiovascular Disease $2,577